These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32967229)

  • 1. Immune Checkpoints in Viral Infections.
    Cai H; Liu G; Zhong J; Zheng K; Xiao H; Li C; Song X; Li Y; Xu C; Wu H; He Z; Zhu Q
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32967229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets.
    Tsai HF; Hsu PN
    J Biomed Sci; 2017 May; 24(1):35. PubMed ID: 28545567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of IL-10 in regulating immunity to persistent viral infections.
    Wilson EB; Brooks DG
    Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Era of Immune Checkpoint Therapy: From Cancer to Viral Infection-A Mini Comment on the 2018 Medicine Nobel Prize.
    Liu J; Pan W; Yang D
    Virol Sin; 2018 Dec; 33(6):467-471. PubMed ID: 30570713
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral interference and interferon.
    Dianzani F
    Ric Clin Lab; 1975; 5(3):196-213. PubMed ID: 778995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral pathogenesis, modulation of immune receptor signaling and treatment.
    Kim WM; Sigalov AB
    Adv Exp Med Biol; 2008; 640():325-49. PubMed ID: 19065800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral strategies for evading antiviral cellular immune responses of the host.
    Iannello A; Debbeche O; Martin E; Attalah LH; Samarani S; Ahmad A
    J Leukoc Biol; 2006 Jan; 79(1):16-35. PubMed ID: 16204622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-viral immunodeficiencies in man.
    Hobbs JR
    Clin Ter; 1992 Feb; 140(2):115-21. PubMed ID: 1568355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies in diseases of viral origin].
    Aguilar Setién A; Kretschmer R
    Salud Publica Mex; 1985; 27(3):251-9. PubMed ID: 2996158
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of viral infections.
    Hegde NR; Rao PP; Bayry J; Kaveri SV
    Immunotherapy; 2009 Jul; 1(4):691-711. PubMed ID: 20635993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Ecosystem of Virus-Infected Host Tissues.
    Maarouf M; Rai KR; Goraya MU; Chen JL
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive mechanisms during viral infectious diseases.
    Sarikonda G; von Herrath MG
    Methods Mol Biol; 2011; 677():431-47. PubMed ID: 20941625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 and the resolution of infections.
    Filippi CM; von Herrath MG
    J Pathol; 2008 Jan; 214(2):224-30. PubMed ID: 18161757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of Anti-Viral Vaccines with Biologic Agents and Immunomodulators in Individuals with Autoimmune and Autoinflammatory Diseases.
    Ostrov BE; Amsterdam D
    Immunol Invest; 2021 Oct; 50(7):833-856. PubMed ID: 33941025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosenescence: what does it mean to health outcomes in older adults?
    McElhaney JE; Effros RB
    Curr Opin Immunol; 2009 Aug; 21(4):418-24. PubMed ID: 19570667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.
    Lambour J; Naranjo-Gomez M; Piechaczyk M; Pelegrin M
    Emerg Microbes Infect; 2016 Aug; 5(8):e92. PubMed ID: 27530750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitors win the 2018 Nobel Prize.
    Huang PW; Chang JW
    Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity.
    Szabo G; Dolganiuc A
    Crit Rev Immunol; 2008; 28(1):61-94. PubMed ID: 18298384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.
    Wortzman ME; Clouthier DL; McPherson AJ; Lin GH; Watts TH
    Immunol Rev; 2013 Sep; 255(1):125-48. PubMed ID: 23947352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaustion and Inflation at Antipodes of T Cell Responses to Chronic Virus Infection.
    Cicin-Sain L; Arens R
    Trends Microbiol; 2018 Jun; 26(6):498-509. PubMed ID: 29249600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.